Of 21 asymptomatic cTnT-positive athletes, all but one (critical CAD) showed no signs of myocardial damage 3 months after an endurance competition during a comprehensive cardiac assessment [29]. The gene discussed is TNNT2; the disease is coronary artery disorder.